We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Collaboration to Study Automated 3D Breast Ultrasound Technology

By HospiMedica International staff writers
Posted on 08 Apr 2010
New ultrasound technology, used in a warm water tank, captures three-dimensional (3D) images of the breast as a woman lies prone on a table.

TechniScan Medical Systems (Salt Lake City, UT, USA), a medical device company focused on the development and commercialization of automated 3D breast ultrasound imaging systems, announced that in collaboration with University Medical Center Freiburg (Germany) it has launched a clinical study to assess clinical utility of TechniScan's warm bath ultrasound (WBU) technology. More...
The University Medical Center Breast Examination Center of the radiology department, University Medical Center Freiburg, is a regional center for women's health and was noted as an the ideal place for the study.

Clinicians will scan at least 150 women within three defined groups: Those with normal mammography findings, those with known benign lesions, and those with known malignancies. The study includes direct comparison of TechniScan's WBU images against mammogram, magnetic resonance imaging (MRI), and hand-held ultrasound to evaluate directly the ability of WBU in providing comparative diagnostic findings.

Medical imaging company Esaote (Genova, Italy) worked with TechniScan in the development of the WBU system and will support TechniScan's efforts in Europe and in Italy. "The Warm Bath Ultrasound system has been developed with groundbreaking science and technology,” said Dr. Luigi Satragno, R&D and strategic marketing general manager of Esaote. "We look forward to seeing the clinical studies results and to a long and productive partnership with TechniScan.”

Radiologists involved in the Freiburg study will utilize TechniScan's imaging network, which provides them with the ability to archive, store, and retrieve anonymous WBU images and relevant medical records and will discuss and compare their results with other researchers.

"Our vision is to begin to create a database of thousands of anonymous breast images and related data,” said Dave Robinson, chief executive officer at TechniScan. "This scientific database will consist of anonymous mammograms, breast MRIs, and WBU images, along with related pathology and other information, to provide researchers around the world an unprecedented opportunity to study breast cancer. The concept is simple, yet revolutionary within the medical system and represents a key competitive advantage of the TechniScan system.”

Esaote is one of the fastest growing medical imaging companies in the world specializing in high-performance ultrasound systems and is a key investor in TechniScan. Esaote's hand-held ultrasound system, the MyLab 70 XVG, is integrated into TechniScan's Warm Bath Ultrasound system to provide both automated reflection imaging and to aid in hand-guided breast biopsy. As the key original manufacture equipment (OEM) supplier for the WBU system, Esaote provides TechniScan with support for engineering, regulatory, and manufacturing initiatives.

TechniScan is a medical device company engaged in the development and commercialization of a noninvasive imaging tool designed to provide physicians with automated ultrasound images of the human breast. The system uses a process (WBU) to provide physicians with automated, 3D ultrasound images of the physical structures within the breast. TechniScan's WBU imaging device is limited by U.S. law to investigational use until cleared by the U.S. Food and Drug Administration (FDA).

Related Links:

TechniScan Medical Systems
University Medical Center Freiburg
Esaote



Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.